BlackRock Global Funds - Global Equity Income Fund D5G USDRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.0 | 18.7 | -3.4 | 9.7 | 4.0 | |
+/-Cat | 1.2 | 0.5 | -2.6 | 2.4 | -0.4 | |
+/-B’mrk | - | -1.6 | -10.2 | 4.9 | -1.5 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 17/05/2024 | USD 17.69 | |
Day Change | -0.29% | |
Morningstar Category™ | Global Equity Income | |
ISIN | LU0827881235 | |
Fund Size (Mil) 30/04/2024 | USD 905.80 | |
Share Class Size (Mil) 17/05/2024 | USD 9.83 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 09/02/2023 | 1.07% |
Investment Objective: BlackRock Global Funds - Global Equity Income Fund D5G USD |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Olivia Treharne 01/02/2020 | ||
Molly Greenen 12/01/2022 | ||
Inception Date 27/09/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - Global Equity Income Fund D5G USD | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.70 |
AstraZeneca PLC | Healthcare | 3.39 |
Novo Nordisk A/S Class B | Healthcare | 3.27 |
Taiwan Semiconductor Manufacturi... | Technology | 3.14 |
Texas Instruments Inc | Technology | 3.06 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - Global Equity Income Fund D5G USD |